of a wastewater treatment system and a water purifier system of an IEC project in Rayong province. Mr. Bhusana and Mr. Maruphong had signed in acceptance of the complete construction and approved the

's Q3/2019 performance would significantly improve because of receive a huge medical treatment income of chronic diseases from Social Security Office through his securities trading accounts during 10

about CHG's Q3/2019 performance would significantly improve because of receive a huge medical treatment income of chronic diseases from Social Security Office through her securities trading accounts

follows; 1.1 Sales of Biodiesel, Edible oil Refined Glycerine, Raw material and By-product ▪ For the year 2022, The sales volume decreased by 10.58% and the revenue from Biodiesel business decrease by

alleviates the impact of the risk on the Company’s performance. Therefore, the Company has invested in the Refined Glycerine plant according to the Company's strategy plan, which add the value-added to by

water, wastewater treatment and hydrogen and supplies its utilities to the Artlant PTA plant. PTA is a core strategic business of IVL and we are confident that over time the Portugal PTA plant will

subsidiary for Quarter 1 of 2019 ending on 31 March 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st

suppliers. The plant now has been completed but still in the process of mechanical testing and improving the treatment formula. For the RDF facility in the second quarter, the Company has started to adjust

Q2/2019 ∆% Q1/2020 ∆% Revenues from sales of medical equipment and services 431,618 440,596 -2% 301,848 43% Revenues from sales and beauty treatment services 3,568 43,985 -92% 22,202 -84% Interest

perform duties or provide services honestly and a wrongful treatment of investor assets in contravention of the governing Notification of the Capital Market Supervisory Board. The SEC therefore revoked his